Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
3M agrees to $7.35 billion settlement of PFAS personal injury claims

3M agrees to $7.35 billion settlement of PFAS personal injury claims

BitgetBitget2026/11/03 23:01
  • 3M agreed to pay $7.35 billion over nine years through 2034 to settle PFAS-related personal injury claims.
  • The resolution covers approximately 99% of current claims inside and outside South Carolina’s AFFF multidistrict litigation, involving approximately 115,000-120,000 eligible plaintiffs.
  • A $5.8 billion pretax charge, reflecting the settlement’s present value, will be recorded in fourth-quarter 2026; full-year guidance remains unchanged.
  • Payments include $50 million in 2026, none in 2027 and approximately 20% of the total in the final two years.
  • The commitment includes a $680 million reserve fund to help manage remaining and future personal injury claims.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3M Company published the original content used to generate this news brief via PR Newswire (Ref. ID: CG88390) on November 03, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs comments on AMD (AMD.US) Q3 performance: Data center CPU and GPU show strong performance, growth visibility for 2027 is clear

Goldman Sachs released a research report maintaining a "Buy" rating on AMD (AMD.US) with a 12-month target price of $675.

智通财经•2026/11/04 03:53

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs

AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.

智通财经•2026/11/04 02:51